Arizona State Retirement System Ligand Pharmaceuticals Inc Transaction History

Arizona State Retirement System

  • $15.6 Billion
  • Q3 2024

A detailed history of Arizona State Retirement System transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Arizona State Retirement System holds 5,172 shares of LGND stock, worth $592,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,172
Previous 4,708 9.86%
Holding current value
$592,918
Previous $396,000 30.81%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$82.7 - $110.11 $38,372 - $51,091
464 Added 9.86%
5,172 $518,000
Q2 2024

Aug 05, 2024
BUY
$68.53 - $87.91 $10,690 - $13,713
156 Added 3.43%
4,708 $396,000
Q1 2024

May 07, 2024
SELL
$68.64 - $89.2 $3,981 - $5,173
-58 Reduced 1.26%
4,552 $332,000
Q4 2023

Jan 24, 2024
SELL
$49.57 - $72.63 $3,073 - $4,503
-62 Reduced 1.33%
4,610 $329,000
Q3 2023

Nov 06, 2023
BUY
$58.86 - $72.67 $6,768 - $8,357
115 Added 2.52%
4,672 $279,000
Q2 2023

Aug 01, 2023
SELL
$69.53 - $79.33 $23,501 - $26,813
-338 Reduced 6.91%
4,557 $328,000
Q1 2023

Apr 27, 2023
BUY
$65.67 - $77.08 $8,668 - $10,174
132 Added 2.77%
4,895 $360,000
Q4 2022

Feb 07, 2023
BUY
$61.72 - $96.74 $11,171 - $17,509
181 Added 3.95%
4,763 $318,000
Q3 2022

Nov 07, 2022
BUY
$0.01 - $107.56 $0 - $5,700
53 Added 1.17%
4,582 $395,000
Q2 2022

Jul 28, 2022
BUY
$74.52 - $117.06 $894 - $1,404
12 Added 0.27%
4,529 $404,000
Q1 2022

May 04, 2022
BUY
$94.99 - $151.56 $2,754 - $4,395
29 Added 0.65%
4,517 $508,000
Q4 2021

Feb 04, 2022
SELL
$127.69 - $165.85 $6,129 - $7,960
-48 Reduced 1.06%
4,488 $693,000
Q3 2021

Nov 12, 2021
BUY
$102.33 - $144.73 $2,046 - $2,894
20 Added 0.44%
4,536 $632,000
Q2 2021

Aug 02, 2021
SELL
$113.03 - $155.64 $18,649 - $25,680
-165 Reduced 3.52%
4,516 $592,000
Q1 2021

May 06, 2021
BUY
$99.52 - $215.83 $2,089 - $4,532
21 Added 0.45%
4,681 $714,000
Q4 2020

Jan 28, 2021
SELL
$80.55 - $106.05 $14,660 - $19,301
-182 Reduced 3.76%
4,660 $463,000
Q3 2020

Nov 05, 2020
BUY
$89.56 - $126.72 $100,038 - $141,546
1,117 Added 29.99%
4,842 $462,000
Q2 2020

Aug 04, 2020
SELL
$68.28 - $123.65 $27,175 - $49,212
-398 Reduced 9.65%
3,725 $417,000
Q1 2020

May 05, 2020
SELL
$63.37 - $107.88 $369,827 - $629,587
-5,836 Reduced 58.6%
4,123 $300,000
Q4 2019

Jan 27, 2020
SELL
$96.94 - $113.59 $183,119 - $214,571
-1,889 Reduced 15.94%
9,959 $1.04 Million
Q3 2019

Oct 31, 2019
SELL
$86.25 - $120.16 $204,930 - $285,500
-2,376 Reduced 16.7%
11,848 $1.18 Million
Q2 2019

Jul 25, 2019
SELL
$107.38 - $129.34 $49,072 - $59,108
-457 Reduced 3.11%
14,224 $1.62 Million
Q1 2019

Apr 29, 2019
SELL
$105.93 - $142.47 $60,803 - $81,777
-574 Reduced 3.76%
14,681 $1.85 Million
Q4 2018

Jan 28, 2019
SELL
$128.36 - $272.13 $1.97 Million - $4.18 Million
-15,359 Reduced 50.17%
15,255 $2.07 Million
Q3 2018

Oct 29, 2018
SELL
$211.18 - $274.49 $89,329 - $116,109
-423 Reduced 1.36%
30,614 $8.4 Million
Q2 2018

Aug 07, 2018
SELL
$150.77 - $207.98 $337,121 - $465,043
-2,236 Reduced 6.72%
31,037 $6.43 Million
Q1 2018

May 14, 2018
SELL
$138.63 - $182.62 $304,986 - $401,764
-2,200 Reduced 6.2%
33,273 $5.5 Million
Q4 2017

Feb 09, 2018
BUY
$128.36 - $147.04 $3.16 Million - $3.62 Million
24,598 Added 226.19%
35,473 $4.86 Million
Q3 2017

Nov 14, 2017
BUY
$120.91 - $137.94 $1.31 Million - $1.5 Million
10,875
10,875 $1.48 Million

Others Institutions Holding LGND

# of Institutions
256
Shares Held
18.1M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.94B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email